Why the study?
Young platelets clinically correlate with adverse cardiovascular outcomes, but understanding remains incomplete due to technical limitations in studying platelets of different ages.
Population
Mice
Comparison
Young platelets (<24 hours old) vs older platelets
Design
In vivo preclinical study using temporal labeling
Authors
Loading...
New in vivo labeling enables age-specific platelet studies; leaves open causal links to cardiovascular outcomes.
This novel in vivo labeling technique demonstrates that young platelets are more reactive and thrombogenic than older platelets, independent of size, providing insights into age-based platelet heterogeneity.
Armstrong et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: